# EDGAR Filing Document

**Accession Number:** 0001308547
**File Stem:** 0001193125-23-060046
**Filing Date:** 2023-3
**Character Count:** 19804
**Document Hash:** 576a1e9e1f8aca1923aece6697c5bf7f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-060046.hdr.sgml**: 20230303

**ACCESSION NUMBER**: 0001193125-23-060046

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 5

**FILED AS OF DATE**: 20230303

**DATE AS OF CHANGE**: 20230303

**EFFECTIVENESS DATE**: 20230303

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Dolby Laboratories, Inc.
- **CENTRAL INDEX KEY:** 0001308547
- **STANDARD INDUSTRIAL CLASSIFICATION:** PATENT OWNERS & LESSORS [6794]
- **IRS NUMBER:** 900199783
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0927

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270271
- **FILM NUMBER:** 23704216

**BUSINESS ADDRESS:**
- **STREET 1:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103
- **BUSINESS PHONE:** 415 558 0200

**MAIL ADDRESS:**
- **STREET 1:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103

**As filed with the Securities and Exchange Commission on March 3, 2023** 

**Registration No. 333-** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

------

## DOLBY LABORATORIES, INC.
**(Exact name of Registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Delaware** | **90-0199783** |
| **(State or other jurisdiction**<br> **of incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**Dolby Laboratories, Inc.** 

**1275 Market Street** 

**San Francisco, California 94103-1410** 

**(Address of principal executive offices, including zip code)** 

**2020 STOCK PLAN** 

**(formerly known as the 2005 Stock Plan)** 

**EMPLOYEE STOCK PURCHASE PLAN** 

**(Full title of the plan)** 

**Andy Sherman, Esq.** 

**Executive Vice President, General Counsel and Corporate Secretary** 

**Dolby Laboratories, Inc.** 

**1275 Market Street** 

**San Francisco, California 94103-1410** 

**(415) 558-0200** 

**(Name, address and telephone number, including area code, of agent for service)** 

***Copy to:***

**Mark B. Baudler, Esq.** 

**Wilson Sonsini Goodrich & Rosati** 

**Professional Corporation** 

**650 Page Mill Road** 

**Palo Alto, CA 94304-1050** 

**(650) 493-9300** 

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**REGISTRATION OF ADDITIONAL SECURITIES** 

**PURSUANT TO GENERAL INSTRUCTION E** 

This Registration Statement registers additional shares of Class A Common Stock of Dolby Laboratories, Inc. (the "Registrant") to be issued pursuant to the Registrant's 2020 Stock Plan, as amended and restated (the "2020 Stock Plan"), formerly known as the 2005 Stock Plan and the Employee Stock Purchase Plan, as amended and restated (the "ESPP"). Accordingly, the contents of (i) the previous Registration Statement on Form S-8 (File No. 333-122908) filed by the Registrant with the Securities and Exchange Commission (the "SEC") on [February 18, 2005](http://www.sec.gov/Archives/edgar/data/1308547/000119312505033046/ds8.htm), (ii) the previous Registration Statement on Form S-8 (File No. 333-150804) filed by the Registrant with the SEC on [May 9, 2008](http://www.sec.gov/Archives/edgar/data/1308547/000119312508109781/ds8.htm), (iii) the previous Registration Statement on Form S-8 (File No. 333-174319) filed by the Registrant with the SEC on [May 18, 2011](http://www.sec.gov/Archives/edgar/data/1308547/000119312511144306/ds8.htm), (iv) the previous Registration Statement on Form S-8 (File No. 333-188602) filed by the Registrant with the SEC on [May 14, 2013](http://www.sec.gov/Archives/edgar/data/1308547/000119312513219889/d531396ds8.htm), (v) the previous Registration Statement on Form S-8 (File No. 333-202012) filed by the Registrant with the SEC on [February 11, 2015](http://www.sec.gov/Archives/edgar/data/1308547/000119312515042874/d859800ds8.htm), (vi) the previous Registration Statement on Form S-8 (File No. 333-216058) filed by the Registrant with the SEC on [February 14, 2017](http://www.sec.gov/Archives/edgar/data/1308547/000119312517043464/d236203ds8.htm) and (vii) the previous Registration Statement on Form S-8 (File No. 333-236622) filed by the Registrant with the SEC on [February 25, 2020](http://www.sec.gov/Archives/edgar/data/1308547/000119312520048394/d851725ds8.htm) are incorporated by reference into this Registration Statement pursuant to General Instruction E of Form S-8.

**PART II** 

**INFORMATION REQUIRED IN REGISTRATION STATEMENT** 

**Item 3. Incorporation of Documents by Reference.** 

The following documents previously filed with the SEC by the Registrant are hereby incorporated by reference into this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Registrant's Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001308547/000162828022030390/dlb-20220930.htm) for the fiscal year ended September 30, 2022, filed with the SEC on November 18, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) All other reports filed by the Registrant with the SEC pursuant to Sections 13(a) or 15(d) of the Exchange Act
since the end of the fiscal year covered by the Registrant's Annual Report referred to in (1) above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) The description of the Registrant's Class A common stock contained in the Registrant's
Registration Statement on [Form 8-A](http://www.sec.gov/Archives/edgar/data/1308547/000119312505023551/d8a12b.htm) filed with the Commission on February 9, 2005, pursuant to Section 12(b)
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including any amendment or report filed for the purpose of updating such description.

All documents filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; *provided, however*, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or superseded such statement.

------

**Item 8. Exhibits.** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Exhibit<br>Number** | **Exhibit Description** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** |
| **Exhibit<br>Number** | **Exhibit Description** | **Form** | **File No.** | **Exhibit** | **Filing Date** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 | [Form of Registrant's Class A common stock certificate.](http://www.sec.gov/Archives/edgar/data/1308547/000119312504221162/dex41.htm) | S-1/A | 333-120614 | 4.1 | December 30, 2004 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 | [2020 Stock Plan (as amended and restated on February 7, 2023)](http://www.sec.gov/Archives/edgar/data/1308547/000119312523032624/d645316dex101.htm) | 8-K | 001-32431 | 10.1 | February 10, 2023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 | [Employee Stock Purchase Plan (as amended and restated on February 7, 2023)](http://www.sec.gov/Archives/edgar/data/1308547/000119312523032624/d645316dex102.htm) | 8-K | 001-32431 | 10.2 | February 10, 2023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 | [Form of Global Stock Option Agreement under the 2020 Stock Plan](http://www.sec.gov/Archives/edgar/data/1308547/000162828017000745/exhibit101-globalstockopti.htm) | 10-Q | 001-32431 | 10.1 | February 2, 2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5 | [Form of Executive Global Stock Option Agreement under the 2020 Stock Plan](http://www.sec.gov/Archives/edgar/data/1308547/000162828017000745/exhibit102-executiveglobal.htm) | 10-Q | 001-32431 | 10.2 | February 2, 2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6 | [Form of Global Restricted Stock Unit Agreement under the 2020 Stock Plan](http://www.sec.gov/Archives/edgar/data/1308547/000162828017000745/exhibit103-globalrsuform.htm) | 10-Q | 001-32431 | 10.3 | February 2, 2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7 | [Form of Executive Global Restricted Stock Unit Agreement under the 2020 Stock Plan](http://www.sec.gov/Archives/edgar/data/1308547/000162828017000745/exhibit104-executiversuform.htm) | 10-Q | 001-32431 | 10.4 | February 2, 2017 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8 | [Form of Executive Performance-Based Stock Option Agreement](http://www.sec.gov/Archives/edgar/data/1308547/000119312515401472/d102497dex992.htm) | 8-K | 001-32431 | 99.2 | December 11, 2015 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.9 | [Form of Executive Performance-Based Restricted Stock Unit Agreement](http://www.sec.gov/Archives/edgar/data/1308547/000162828020000702/exhibit101-q120.htm) | 10-Q | 001-32431 | 10.1 | January 29, 2020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.10 | [Form of Subscription Agreement under the ESPP – U.S. Employees](http://www.sec.gov/Archives/edgar/data/1308547/000119312509237809/dex1011.htm) | 10-K | 001-32431 | 10.11 | November 19, 2009 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.11 | [Form of Subscription Agreement under the ESPP – Non-U.S. Employees](http://www.sec.gov/Archives/edgar/data/1308547/000130854712000007/a2012q3ex-101.htm) | 10-Q | 001-32431 | 10.1 | August 8, 2012 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 | [Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation](d468242dex51.htm) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;23.1 | [Consent of KPMG LLP, Independent Registered Public Accounting Firm](d468242dex231.htm) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;23.2 | [Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (see Exhibit 5.1)](d468242dex51.htm) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;24.1 | [Power of Attorney (contained on signature page hereto)](d468242ds8.htm#sig) |  |  |  |  |
| 107 | [Filing Fee Table](d468242dexfilingfees.htm) |  |  |  |  |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Francisco, State of California, on the 3<sup>rd</sup> day of March, 2023.

---

| | |
|:---|:---|
| DOLBY LABORATORIES, INC. | DOLBY LABORATORIES, INC. |
| By: | /S/ KEVIN J. YEAMAN |
|  | Kevin J. Yeaman |
|  | President and Chief Executive Officer |
|  | (Principal Executive Officer) |

---

**POWER OF ATTORNEY** 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin J. Yeaman and Robert Park, his or her attorney-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Registration Statement on Form S-8, and to file the same, with exhibits thereto and other documents in connections therewith, with the Securities and Exchange Commission, hereby ratifying and conforming all that each of said attorneys-in-fact, or his substitutes, may do or cause to be done by virtue of hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **SIGNATURE** | **TITLE** | **DATE** |
| /S/ PETER GOTCHER<br> **Peter Gotcher** | Chairman of the Board of Directors | March 3, 2023 |
| /S/ KEVIN J. YEAMAN<br> **Kevin J. Yeaman** | President, Chief Executive Officer and Director (Principal Executive Officer) | March 3, 2023 |
| /S/ ROBERT PARK<br> **Robert Park** | Senior Vice President and Chief Financial Officer (Principal Financial Officer) | March 3, 2023 |
| /S/ RYAN NICHOLSON<br> **Ryan Nicholson** | Vice President, Chief Accounting Officer (Principal Accounting Officer) | March 3, 2023 |
| /S/ MICHELINE CHAU<br> **Micheline Chau** | Director | March 3, 2023 |
| /S/ DAVID DOLBY<br> **David Dolby** | Director | March 3, 2023 |
| /S/ TONY PROPHET<br> **Tony Prophet** | Director | March 3, 2023 |
| /S/ EMILY ROLLINS<br> **Emily Rollins** | Director | March 3, 2023 |
| /S/ SIMON SEGARS<br> **Simon Segars** | Director | March 3, 2023 |
| /S/ ANJALI SUD<br> **Anjali Sud** | Director | March 3, 2023 |
| /S/ AVADIS TEVANIAN, JR.<br> **Avadis Tevanian, Jr.** | Director | March 3, 2023 |

---

## Exhibit 5.1

**Exhibit 5.1** 

---

| | |
|:---|:---|
| ![LOGO](g468242g0302085948478.jpg) | Wilson Sonsini Goodrich & Rosati<br> Professional Corporation<br>650 Page Mill Road<br> Palo Alto, California 94304-1050<br>O: 650.493.9300<br> F: 650.493.6811 |

---

March 3, 2023

Dolby Laboratories, Inc.

1275 Market Street

San Francisco, California 94103-1410

**Re: Registration Statement on Form S-8** 

Ladies and Gentlemen:

We have examined the Registration Statement on Form S-8 (the "<u>Registration Statement</u>") to be filed by Dolby Laboratories, Inc., a Delaware corporation (the "<u>Company</u>"), with the Securities and Exchange Commission on or about the date hereof, in connection with the registration under the Securities Act of 1933, as amended, of an aggregate of 10,500,000 shares of the Company's Class A common stock, par value $0.001 per share (the "<u>Shares</u>"), consisting of (i) 9,000,000 shares of the Company's Class A common stock reserved for issuance pursuant to the Company's Amended and Restated 2020 Stock Plan (the "<u>Plan</u>"), and (ii) 1,500,000 shares of the Company's Class A common stock reserved for issuance pursuant to the Company's Amended and Restated Employee Stock Purchase Plan (the "<u>ESPP</u>"). As the Company's legal counsel, we have reviewed the actions proposed to be taken by the Company in connection with the issuance and sale of the Shares to be issued under the Plan and the ESPP.

It is our opinion that the Shares, when issued and sold in the manner referred to in the Plan and the ESPP and pursuant to the agreements that accompany the Plan and the ESPP, will be legally and validly issued, fully paid and nonassessable.

We consent to the use of this opinion as an exhibit to the Registration Statement, and further consent to the use of our name wherever appearing in the Registration Statement and any amendments thereto.

---

| |
|:---|
| Very truly yours, |
| /s/ WILSON SONSINI GOODRICH & ROSATI<br>WILSON SONSINI GOODRICH & ROSATI |
| Professional Corporation |

---

AUSTIN BEIJING BOSTON BRUSSELS HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO

SAN DIEGO SAN FRANCISCO SEATTLE SHANGHAI WASHINGTON, DC WILMINGTON, DE

## Exhibit 23.1

**Exhibit 23.1** 

**Consent of Independent Registered Public Accounting Firm** 

We consent to the use of our report dated November 17, 2022, with respect to the consolidated financial statements of Dolby Laboratories, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.

/s/ KPMG LLP

San Francisco, California

March 3, 2023

## Ex-Filing

**Exhibit 107** 

**CALCULATION OF REGISTRATION FEE** 

**Form S-8** 

(Form Type)

**Dolby Laboratories, Inc.** 

(Exact name of registrant as specified in its charter)

**Table 1 – Newly Registered Securities** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;**Security Type** | **Security**<br> **Class**<br> **Title** | **Fee**<br> **Calculation**<br> **Rule** | **Amount<br>Registered<sup>(1)</sup>** | **Maximum**<br> **Aggregate Offering<br>Price** | **Fee**<br> **Rate** | **Amount of<br>Registration<br>Fee** |
| &nbsp;&nbsp;&nbsp;Equity | Class A common stock, $0.001 par value per share, reserved for issuance pursuant to the 2020 Stock Plan | Rule 457(c) and Rule 457(h) | 9000000$82.06<sup>(2)</sup> | $738540000.00 | 0.00011020 | $81387.11 |
| &nbsp;&nbsp;&nbsp;Equity | Class A common stock, $0.001 par value per share, reserved for issuance pursuant to the ESPP | Rule 457(c) and Rule 457(h) | 1500000$69.75<sup>(3)</sup> | $104626500.00 | 0.00011020 | $11529.84 |
| &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | $843166500.00 |  | $92916.95 |
| &nbsp;&nbsp;&nbsp;Total Fee Offsets<sup>(4)</sup> | &nbsp;&nbsp;&nbsp;Total Fee Offsets<sup>(4)</sup> | &nbsp;&nbsp;&nbsp;Total Fee Offsets<sup>(4)</sup> | &nbsp;&nbsp;&nbsp;Total Fee Offsets<sup>(4)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due |  |  | $92916.95 |

---

1. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the "Securities Act"), this
Registration Statement covers any additional shares of the Registrant's Class A common stock that become issuable under the 2020 Stock Plan and the ESPP, by reason of any stock dividend, stock split, recapitalization or other similar
transaction effected without the Registrant's receipt of consideration that results in an increase in the number of outstanding shares of Class A common stock.

2. Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of
calculating the registration fee on the basis of $82.06 per share, which is the average of the high and low prices of Class A common stock, as reported on the New York Stock Exchange, on February 24, 2023 (such average, the "Full
Offering Price").

3. Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of
calculating the registration fee on the basis of 85% of the Full Offering Price. Pursuant to the ESPP, which plan is incorporated by reference herein, the purchase price of the shares of Class A common stock will be 85% of the lower of the fair
market value of the Class A common stock on the first trading day of the offering period or on the first trading day on or after May 15 and November 15 of the related purchase periods.

4. The Registrant does not have any fee offsets.